Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q1 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
MET:US | MetLife Inc. | Common share | - | US59156R1086 | $81.02 |
Company name | MetLife |
---|---|
Tags | #s&p500 index |
Sector | Financials / Insurance / Insurance / Life & Health Insurance |
Business address | 200 PARK AVENUE NEW YORK NY 10166 212-578-5500 |
Mailing address | 200 PARK AVENUE NEW YORK NY 10166 |
Website | investor.metlife.com |
Information disclosure | www.sec.gov |